To further investigate whether the expression level of Pygo2 correlates with the survival of glioma patients, Kaplan-Meier analysis for the WHO tumor phases of 209 human brain glioma patients and 9 normal subjects was used (Fig. 2). The gene discussed is PYGO2; the disease is central nervous system cancer.